NGS Automation Market Updates

Global NGS Automation Market size was valued at USD 0.4 million in 2023 and is poised to grow from USD 0.45 million in 2024 to USD 1.24 million by 2032, growing at a CAGR of 13.4% during the forecast period (2025-2032).

The competitive landscape for the next-generation sequencing (NGS) market includes information by competitor. An overview of the business, financials, revenue generated, market potential, investments in R&D, new market initiatives, production facilities, company strengths and weaknesses, product launches, product approval pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve are among the details provided. The data metrics mentioned above only pertain to the company's market focus on next-generation sequencing (NGS). 'Thermo Fisher Scientific Inc. (USA) ', 'Agilent Technologies, Inc. (USA) ', 'PerkinElmer, Inc. (USA) ', 'Roche Holding AG (Switzerland) ', 'Danaher Corporation (USA) ', 'Tecan Group Ltd. (Switzerland) ', 'Hamilton Company (USA) ', 'Eppendorf AG (Germany) ', 'Hudson Robotics (USA) ', '10x Genomics, Inc. (USA) ', 'Bio-Rad Laboratories, Inc. (USA) ', 'Illumina, Inc. (USA) ', 'Becton, Dickinson and Company (BD) (USA) ', 'Honeywell International Inc. (USA) ', 'Siemens AG (Germany) ', 'Abbott Laboratories (USA) ', 'LabCorp (Laboratory Corporation of America Holdings) (USA) ', 'Charles River Laboratories International, Inc. (USA) ', 'Brooks Life Sciences (USA)'

The increased demand for automation in NGS workflow, the prevalence of cancer, rising R&D spending, and rising healthcare costs are just a few of the reasons contributing to the expansion of this industry. Additionally, this market is anticipated to experience significant expansion due to the expanding uses of next-generation sequencing and the growing number of corporate partnerships to create library preparation techniques.

Automation of NGS library preparation enables dependable and repeatable data creation by assisting researchers in library quality improvement and consistent yields. It also improves productivity and lowers costs. Reducing manual contact with the reagents and samples significantly lowers the risk of contamination. As a result, the market for NGS automation is anticipated to be driven by the rising demand for automation in NGS workflow.

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). The NGS automation market is expected to be dominated by North America, followed by Europe and Asia-Pacific. The significant market share held by North America is due in large part to the region's high R&D expenditures, growing demand for NGS automation in the pharmaceutical and biotech sectors, and expanding government support and investment in the region's genome sequencing infrastructure.